Moreover, a minority of T-cell clones yielded ex vivo reaction against HLA-A*02:01-positive primary blasts from AML patients harboring NPM1 gene mutations, whereas no T-cell reactivity was observed against HLA-A*02:01-positive AML with wild-type NPM1 [20]. This evidence concerns the gene NPM1 and acute myeloid leukemia.